12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers

  • TransMedics Group TMDX stock moved upwards by 16.4% to $75.1 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. The company's, Q4 earnings came out yesterday.
  • Adamis Pharmaceuticals ADMP stock rose 15.23% to $0.32. The market value of their outstanding shares is at $47.9 million.
  • Jounce Therapeutics JNCE stock moved upwards by 15.1% to $1.14. The company's market cap stands at $58.9 million.
  • Celyad Oncology CYAD stock moved upwards by 14.91% to $1.31. The market value of their outstanding shares is at $29.5 million.
  • Calliditas Therapeutics CALT shares moved upwards by 13.72% to $20.47. The market value of their outstanding shares is at $609.8 million. As per the press release, Q4 earnings came out today.
  • Lantheus Holdings LNTH stock rose 12.44% to $65.5. The market value of their outstanding shares is at $4.5 billion. As per the press release, Q4 earnings came out today.

Losers

  • Lucira Health LHDX stock fell 38.0% to $0.14 during Thursday's pre-market session. The company's market cap stands at $5.7 million.
  • Infinity Pharmaceuticals INFI stock declined by 29.1% to $0.39. The market value of their outstanding shares is at $34.8 million.
  • Aprea Therapeutics APRE stock declined by 14.43% to $5.4. The company's market cap stands at $14.3 million.
  • Assertio Holdings ASRT shares fell 8.41% to $4.9. The company's market cap stands at $236.6 million.
  • Immix Biopharma IMMX shares decreased by 8.19% to $2.13. The market value of their outstanding shares is at $29.6 million.
  • Processa Pharma PCSA shares declined by 8.13% to $0.66. The company's market cap stands at $16.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!